Denileukin Diftitox in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment - Related Studies

Denileukin Diftitox in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

This study is currently recruiting participants.

Study NCT00425672. Last updated on November 14, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		denileukin diftitox
		flow cytometry
		immunoenzyme technique
		laboratory biomarker analysis
		protein expression analysis

5	Additional drug interventions recognized in this trial
		Interleukin-2

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Antineoplastic Agents
		Central Nervous System Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Fred Hutchinson Cancer Research Center
		National Cancer Institute (NCI)